2Ofin SL, Benjamin S, Nathaniel P, et al. Development, evaluation and implementation of Haemophilus influenzae type b vaccines for young childrn in developing country: Current staus and priorityactions[J]. Pediatr Infect Dis J 1998, 17(supple) : 95-113.
3Henk AB. Word-wide epidemiology of Haemophilus influenzae mening it is industrialized versus non-indstrialized countries[J].Vaeeine 1991,9(supple) : 5-9.
4Yang YH, Leng ZQ, Shen XZ, et al. Acute bacterial mening it is in Hefei city, China, 1990-1992[J]. Chinese J Med 1996, 109:385 -388.
5CDC. Recommendations for use of Haemophilus b conjugate vaccines and combined diphtheria, tetanus, pertussis, and Haemophilus b vaccine: recommendations of the Advisory Committeeon Immunization Practice (ACIP) [J]. MMWR 1993, 42( RR-13) : 1-15.
6Greenberg DP, Wong VK, Partridge S, et al. Immunogenieity of a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine when mixed with a diphtheria-tetanus-acellular pertussis-hepatitis B combination vaeeine[ J]. Pediatr Infect Dis J 2000, 19(12) :1135-1140.
7Omenaca F, Dal-Re R, D'Apuzzo V, et al. Reactogenicity of DTPa-HBV/Hib vaccine administered as a single injection vs DTPa-HBV and Hib vaccines administered simultaneously at separate sites, to infants at 2, 4 and 6 months of age[J]. Vaccine 2001,19(30): 4260-4266.
8Aristegui J, Dal-Re R, Garrote E, et al. Assessment of the immunogenieity and reaetogenieity of a quadrivalent diphtheria, tetanus,acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at 2, 4 and 6 months of age[ J ]. Vaccine 1998,16(20) : 1976-1981.
9Mills E, Gold R, Thipphawong J, et al. Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanusinactivated poliomyelitis-Haemophilus b conjugate vaccine administered to infants at two, four and six months of age[ J]. Vaccine 1998, 16: 576-585.
10MB Rennels, GF Reed, MD Decker, et al. Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccines[ J ]. Pediatrics 1995, 96:576-579.
7Anonymous. Global Programme for V accinees and Immunizati on (GPV). The WHO position paper on Haemophilus -influenzae type b.conjugate vaccines[J']. Week lyep- idemiological Record, 1998, 73(10): 64- 68.
8Ferreccio C, Ortiz E, Astroza L, et al. A population -based ret- rospective assessment of the disease burden resulting frominvasive Haemopbilus influenzae in infants and young children in Santia- go,Chile[J]. PediatrInfect Dis J,1990,9(7) 488 - 494.
9Shaun K Morris, William J Moss, Neal Halsey. Haemophilus in- fluenzae type b conjugate vaccine use and electiveness[J]. Lancet Infect Dis 20081 8.. 435 - 43.
10American Academy of Pediatrics Committee on Infectious Disea- ses. Haemophilus influenzae type b conjugate vaccines recom- mendations for immunization of infants and children 2 months of age and older: update[J]. Pediatrics 1991 88 : 169 - 72.
